Plandaí Biotechnology, Inc. PLPL OTC

Other OTC • Financial Services • Shell Companies • GB • USD

SharesGrow Score

23/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Plandaí Biotechnology, Inc. (PLPL) reported total assets of $100K and total liabilities of $155K for fiscal year 2023, resulting in total equity of $-55K.

The company held $0.00 in cash and short-term investments. Total debt stood at $155K, with net debt of $155K. The Debt-to-Equity (D/E) ratio was -2.82 (conservative).

Current ratio is 0, which may signal tight short-term liquidity.

Criteria supported by this page:

HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (28/100) — Total assets $100K and equity $-55K support the company's competitive scale

Overall SharesGrow Score: 21/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

23/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

PAST

50/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

28/100

→ Income

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Plandaí Biotechnology, Inc. Balance Sheet History

Metric	FY2023	FY2022	FY2021	FY2020
Total Assets	$100K	$0.00	$0.00	$0.00
Total Liabilities	$155K	$442.64K	$1.53M	$9.17M
Total Debt	$155K	$50.18K	$114.96K	$7.03M
Cash & Investments	$0.00	$0.00	$0.00	$0.00
Total Stockholders Equity	$-55K	$-442.64K	$-1.53M	$-9.17M